Adaptive Licensing: Taking the Next Step in the Evolution of Drug Approval

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|91|3|426-437

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.91, Iss.3, 2012-03, pp. : 426-437

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Taking the Next Step: Clinical Research in the Long‐Term Care Facility

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 35, Iss. 2, 1987-02 ,pp. : 174-175

John Wiley & Sons Inc

Access to resources Recommend Favorite

Are high drug loading nanoparticles the next step forward for chemotherapy?

By Della Rocca Joseph   Liu Demin   Lin Wenbin  

Nanomedicine, Vol. 7, Iss. 3, 2012-03 ,pp. : 303-305

Future Medicine

Access to resources Recommend Favorite

Generic drug approval: A US perspective

By Nagori B.P.   Mathur V.   Garg S.  

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 541-545

Informa Healthcare

Access to resources Recommend Favorite

Time for a change in drug licensing requirements?

By Drummond Michael F.  

The European Journal of Health Economics, Vol. 3, Iss. 2, 2002-06 ,pp. : 137-138

Springer Publishing Company

Access to resources Recommend Favorite

Emergency Medicine Milestones: The Next Step

By  

ACADEMIC EMERGENCY MEDICINE, Vol. 22, Iss. 7, 2015-07 ,pp. : 847-848

John Wiley & Sons Inc

Access to resources Recommend Favorite